EPCCS Cardiovascular Literature Updates

Cardiovascular Disease 2012 & European Primary Care:

Get up to date, view state-of-the-art expert opinions by EPCCS faculty on major topics in cardiovascular disease and its relevance for European Primary Care.

Room for improvement in smoking cessation treatment in GP practices

Selected literature
Mallaina P, Lionis C, Rol H, et al.
CV-ASPIRE confirms that smoking is a significant predictor of long-term CV events thus underscores the importance of addressing this modifiable risk factor
Read more...

The benefits of regular exercise training are clear but exploited too little

Selected literature
Schuler G, Adams V, Goto Y.
We summarise the molecular consequences of exercise and strategies to increase compliance to frequent exercise.
Read more...

Extent of second-hand tobacco smoke exposure predicts coronary artery calcification

Selected literature
JACC, March 2013. Exposure to second-hand tobacco smoke is a risk factor for coronary artery calcification, at least as strong as other well-established risk factors. Read more...

Dabigatran and bleeding risk – new FDA analysis

Selected Literature
NEJM, March 2013. Reassuring results on the rates of gastrointestinal and intracranial bleeds with dabigatran from a new analysis of an FDA database. Read more...

CV outcomes in hypertensive patients are affected by BMI

Selected literature
Lancet, february 2013. Calcium-channel blocker-based therapy gives more protection to non-obese patients than does diuretic-based therapy, whereas both regimes are effective in obese patients. Read more...

Support for prescribing statins as primary prevention

Selected literature
Eur J Prev Cardiol. 2013 Statins reduce all-cause mortality and major coronary events both in patients with cardiovascular disease and in high-risk individuals without disease. Read more...

Mediterranean diet diminishes cardiovascular risk

Selected Literature
NEJM Feb 2013, Suggested protective effect of Mediterranean diet on cardiovascular disease now confirmed in randomised trial. Read more...

Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing PCI

Selected Literature
Dewilde WJ et al. for the WOEST study investigators
Lancet. Feb 2013. Omitting aspirin from antiplatelet regimen reduces the incidence of bleeding, without compromising safety in patients receiving oral anticoagulants undergoing PCI Read more...

Novel use for new anticoagulant dabigatran

Selected Literature
Schulman S, Kearon O, Kakkar AK, et al
NEJM, Feb 2013. New information about the risks and benefits of extended prophylaxis with dabigatran in patients who have had venous thromboembolism (VTE) Read more...

Apixaban for prevention of venous thromboembolism

Selected Literature
NEJM, Feb 2013. New oral factor Xa inhibitor studied for prevention of recurrent venous thromboembolism
Read more...

Cardiovascular dilemmas in case studies

EPCCS 2012 Webcast
View Prof. Martin Scherer, Universitätsklinikum Hamburg-Eppendorf Germany, discusses in case studies the dilemmas general practioners might face in managing cardiovascular disease in daily practice, as also presented during the 5th Annual meeting of the EPCCS in Athens. Get up to date in only 3 minutes Read more...

Diabetes and cardiovascular disease

EPCCS 2012 Webcast
View Prof. Johan Wens, University of Antwerp, Belgium & General Practitioner, discuss the relation of Diabetes and Cardiovascular Disease and its relevance for primary care, as also presented during the 5th Annual meeting of the EPCCS in Athens. Get up to date in only 3 minutes Read more...

Global call for action to reduce cardiovascular risk

Smith SC Jr, Collins A, Ferrari R, et al. EHJ. 2012 Sep 17.
International cardiology group calls for aggressive public health goals. The Global Cardiovascular Disease Taskforce have proposed a set of aggressive measures to help achieve the goal to reduce premature mortality from non-communicable diseases by 25% by the year 2025. Read more...

Update on Familial Hypercholesterolaemia

EPCCS 2012 Webcast
View Dr. Carlos Brotons, Barcelona, Spain, discuss the importance of diagnoses and management of patients with Familial Hypercholesterolaemia in general practice, as also presented during the 5th Annual meeting of the EPCCS in Athens. Get up to date in only 3 minutes
Read more...

New options for stroke prevention in patients with AF

EPCCS 2012 Webcast
View Prof. Richard Hobbs, University of Oxford, United Kingdom, Chairman of EPCCS discussing the potential role of novel anticoagulants in primary care as also presented during the 5th Annual meeting of the EPCCS in Athens. Get up to date in only 3 minutes Read more...

View all expert opinions of EPCCS 2012

Watch all faculty members of EPCCS 2012 provide 3 minute updates on key issues and new developments in cardiovascular disease relevant for primary care
Read more

More EPCCS Commentaries & Literature reviews

Read more
 
What is happening in primary care?

A selection of recent international literature with a focus on primary care & CV disease

May
April

Read more
 
Educational Resources & Literature

EPCCS 2011 - Expert Opinions

View primary care experts discuss the latest developments in cardiovascular disease

New oral anticoagulants for venous thromboembolism

New oral anticoagulants for venous thromboembolism Prof. Henri Bounameaux (Geneva, Switzerland)

Optimising Lipid Management in Stable Disease

Optimising Lipid Management in Stable Disease Prof. Furio Colivicchi (San Filippo Neri Hospital Rome, Italy)

What do GPs need to know about this new CVD epidemic

Prof. Richard McManus (Birmingham, United Kingdom) explains what CKD is and how it should be treated, from the GP viewpoint.

Do biomarkers have a role in CVD prediction or follow-up?

Prof. Arno Hoes (Utrecht, The Netherlands) discusses new biomarkers for predicting of future cardiovascular disease being developed in recent years .

Problems with oral anticoagulants in clinical practice

Dr. Fokko de Haan (Germany) discusses daily problems with the new oral anticoagulants.

The future of lipid management in stroke

Prof. Pierre Amarenco (Paris, France) describes how stroke can be prevented with statins and which patients already having stroke should receive statins.

More expert opinions

My top ten studies in primary care

Prof. Martin Scherer summarizes his favourite publications of primary care studies.

Update on HF Management

Prof. Martin R. Cowie, Imperial College, London, United Kingdom
There have been two very important randomized trials in the field of heart failure in the past 12 months, which should have an impact in everybody’s practice.
 
Welcome to the EPCCS

EPCCS 2013 - London

Register now
Benefit from early registration rates

Become an EPCCS member

Join the EPCCS in our efforts to reduce cardiovascualr disease in Europe. Membership is free. 
The First Pan-European society for healthcare professionals focusing on the management of cardiovascular disease.
Read more

About the EPCCS

Listen to the EPCCS board members to learn more about the EPCCS
Read more

Download
EPCCS 2011 Meeting Highlights

written by dr. Sally Wood
Academic GP Registrar
University of Birmingham/South Birmingham VTS


Read more
© 2011 Medcon International/EPCCS